RECRUITING

The PRISM-Social Needs (PRISM-SN) Intervention for Adolescents and Young Adults With Cancer

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The goal of this study is to establish feasibility, acceptability, and proof-of-concept of an psychosocial intervention adapted to address social health needs of adolescents and young adults (AYAs) newly diagnosed with cancer. The aims of this study are to: 1. Determine if the Promoting Resilience in Stress Management - Social Needs (PRISM-SN) adapted intervention is feasible and acceptable, defined via program uptake and retention and patient-reported feedback. 2. Explore whether PRISM-SN improves social outcomes at 12-week follow-up compared to usual care. Participants will be randomized to receive usual psychosocial care or the PRISM-SN program. Participants on both arms will complete patient-reported outcome surveys at enrollment and 12-weeks later. Researchers will compare participants who received the PRISM-SN program to those who received usual care to see if the program improves psychosocial outcomes.

Official Title

The Promoting Resilience in Stress Management-Social Needs (PRISM-SN) Intervention for Adolescents and Young Adults With Cancer: A Randomized Controlled Trial

Quick Facts

Study Start:2024-05-15
Study Completion:2026-07-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06242964

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:12 Years to 25 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:CHILD, ADULT
Inclusion CriteriaExclusion Criteria
  1. * Aged 12-25 years
  2. * Diagnosed with new malignancy treated with chemotherapy and/or radiation \<6-months
  3. * Able to speak in the English language
  4. * Able to read in the English language
  5. * Cognitively able to participate in intervention sessions and complete surveys
  1. * Aged \<12 or \>25 years
  2. * Diagnosed with recurrent malignancy
  3. * Diagnosed with new malignancy \>6 months
  4. * Not receiving chemotherapy and/or radiation
  5. * Not able to speak in the English language
  6. * Not able to read in the English language
  7. * Not cognitively able to participate in intervention session or complete surveys

Contacts and Locations

Study Contact

Kaitlyn M Fladeboe, PhD
CONTACT
2068844140
katy.fladeboe@seattlechildrens.org

Principal Investigator

Kaitlyn M Fladeboe, PhD
PRINCIPAL_INVESTIGATOR
Seattle Children's

Study Locations (Sites)

Seattle Children's
Seattle, Washington, 98105
United States

Collaborators and Investigators

Sponsor: Seattle Children's Hospital

  • Kaitlyn M Fladeboe, PhD, PRINCIPAL_INVESTIGATOR, Seattle Children's

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-05-15
Study Completion Date2026-07-31

Study Record Updates

Study Start Date2024-05-15
Study Completion Date2026-07-31

Terms related to this study

Additional Relevant MeSH Terms

  • Cancer
  • Social Functioning
  • Psychosocial Functioning
  • Coping Skills